Author: Lee, Seung Heon; Yang, Dong-Kun; Kim, Ha-Hyun; Cho, In-Soo
Title: Efficacy of inactivated variant porcine epidemic diarrhea virus vaccines in growing pigs Document date: 2018_1_29
ID: w643jf90_34
Snippet: Various types of adjuvants are used in inactivated viral vaccines to induce a protective immune response. Therefore, determination of the optimum adjuvant for a particular vaccine is important. In this study, we compared the ability of experimental vaccines formulated with four adjuvants to induce protective immunity against PEDV. Although none of the vaccinated pigs were completely protected against subsequent viral challenge, they developed a s.....
Document: Various types of adjuvants are used in inactivated viral vaccines to induce a protective immune response. Therefore, determination of the optimum adjuvant for a particular vaccine is important. In this study, we compared the ability of experimental vaccines formulated with four adjuvants to induce protective immunity against PEDV. Although none of the vaccinated pigs were completely protected against subsequent viral challenge, they developed a significantly stronger immune response than that of NVC pigs. The strongest antibody responses were detected in pigs that received the vaccines containing oil-based W/O/W emulsion adjuvants, and the ISA206-based vaccine protected against both disease progression and viral shedding. Similarly, a foot and mouth disease vaccine formulated with ISA201 and ISA206 elicited the strongest antibody response and induced protection against the disease [27] [28] [29] . Such formulations also elicit protective immunity against viral and bacterial pathogens in various mammalian species [30, 31] .
Search related documents:
Co phrase search for related documents- adjuvant type and disease mouth foot: 1
- adjuvant type and emulsion adjuvant: 1
- adjuvant type and immune response: 1, 2, 3, 4, 5, 6
- adjuvant type and induced protection: 1
- adjuvant type and mouth foot: 1
- adjuvant type and optimum adjuvant: 1
- adjuvant type and protective immunity: 1, 2
- adjuvant type and viral challenge: 1, 2, 3
- adjuvant type and viral shedding: 1, 2
- adjuvant type and viral vaccine: 1
- antibody response and disease mouth foot: 1, 2, 3, 4, 5, 6
- antibody response and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- antibody response and emulsion adjuvant: 1, 2, 3, 4
- antibody response and experimental vaccine: 1, 2, 3, 4, 5, 6, 7, 8
- antibody response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79
- antibody response and induced protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- antibody response and mouth foot: 1, 2, 3, 4, 5, 6
- antibody response and optimum adjuvant: 1
- antibody response and particular vaccine: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date